Ishikawa cells and HEC-1B cells were treated with the JAK inhibitor NSC 42834 to validate that circCHD7 affects endometrial cancer cell proliferation through the JAK/STAT signaling pathway. This evidence concerns the gene SOAT1 and endometrial cancer.